Chemotherapy
IntroductionTice A.University of Washington School of Medicine, Seattle, Wash., and Infections Limited/Stadium Way Consulting, Tacoma, Wash., USA
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: December 13, 2000
Issue release date: January – February
Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 0
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
First-Page Preview
Related Articles:
References
-
Tice AD: Handbook of Outpatient Parenteral Therapy for Infectious Diseases. New York, Scientific American, 1997.
- Tice AD: Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA. Eur J Clin Microbiol Infect Dis 1995;14:655–661.
- Seaton RA, Nathwani D, Williams FLR, Boyter AC: Feasibility of an outpatient and home parenteral antibiotic therapy (OHPAT) programme in Tayside, Scotland. J Infect 1999;39:129–133.
-
Davey PG, Phillip G, Rowley D: Outpatient management of osteomyelitis. Infect Med 1994;11(suppl C):16–19.
-
Tice AD: Osteomyelitis. Hosp Pract 1993;28(suppl 2):36–39.
-
Lindbeck G, Powers R: Cellulitis. Hosp Pract 1993;28(suppl 2):10–14.
-
Stamboulian D, Bonvehi P, Arevalo C, Bologna R, Cassetti I, Scilingo V, Efron E: Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci. Rev Infect Dis 1991;13(suppl 2):S160–S163.
- Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, Bisno AL, Ferrieri P, Shulman ST, Durack DT: Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci and HACEK microorganisms. JAMA 1995;274:1706–1713.
- Williams DN, Rehm SJ, Tice AD, Bradley JS, Kind AC, Craig WA: Practice guidelines for community-based parenteral anti-infective therapy. Clin Infect Dis 1997;25:787–801.
-
Poretz DM: Infusion center, office, and home. Hosp Pract 1993;28(suppl 2):40–43.
- Francioli P, Ruch W, Stamboulian D, International Infective Endocarditis Study Group: Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: A prospective multicenter study. Clin Infect Dis 1995;21:1406–1410.
-
Lopardo G: Treatment of endocarditis in Argentina (abstract 34.002). 9th International Congress of Infectious Diseases, Buenos Aires, 2000, p 73.
- Nathwani D, Moitra S, Dunbar J, Crosby G, Peterkin G, Davey P: Skin and soft tissue infections: Development of a collaborative management plan between community and hospital care. Int J Clin Pract 1998;52:456–460.
- Halls GA: The management of infections and antibiotic therapy: A European survey. J Antimicrob Chemother 1993;31:985–1000.
Article / Publication Details
Published online: December 13, 2000
Issue release date: January – February
Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 0
ISSN: 0009-3157 (Print)
eISSN: 1421-9794 (Online)
For additional information: https://www.karger.com/CHE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.